Well good luck with that, but MSB already won 2010 International Biotech Licensing Deal of the Year and that deal is worth milestone payments of $1.7billion.
MSB listed at 50c, BTW.
There is no basis for your statement that "the ability to manufacture clinical grade cells at scale with 100% consistency and cost efficiency has eluded all the big names in USA and even MSB " [emphasis added].
Surely you mean that MSB has not progressed to large scale manufacturing yet, but their ability to do so is not in question simply because of this.
Simple Logic.
The fast tracking in Japan should see some scaled up manufacturing before we're all too much older.
Meanwhile MSB is continuing to clear FDA clinical trials. What is anyone waiting for?
lol.
Sorry - what are they waiting for, page-3
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.22%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.700M | 4.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 343780 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 56236 | 13 |
View Market Depth
| Last trade - 13.25pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |